STERIS plc (STE) is a healthcare company providing infection prevention products and services globally, operating through Healthcare, Applied Sterilization Technologies, and Life Sciences segments. The company offers essential items ranging from surgical tables and lighting to contract sterilization for medical device manufacturers, supported by recurring demand across the healthcare and life sciences sectors. As of September 2026, STE pays a quarterly dividend of $0.69, resulting in an annualized rate of $2.58 per share and a current yield of 1.15% based on a stock price of approximately $224.59. The company maintains a conservative payout ratio of 30.7%, distributing less than one-third of its earnings to shareholders, which provides substantial financial room to sustain or grow the dividend even if earnings face pressure. The company has demonstrated a strong track record of dividend growth, achieving a compound annual growth rate (CAGR) of 9.9% from 2011 through 2025. Over this period, the annual dividend per share increased from $0.64 to $2.40, with even the slowest growth year in 2021 outpacing inflation. This consistent growth makes STE attractive for investors seeking a rising income stream rather than a high initial yield. STE is characterized by a beta of 0.914, indicating that its stock price moves slightly less than the broader market, which suits investors looking for dividend growth with reduced volatility. While the current yield is modest compared to high-yield alternatives, it sits above the stock's five-year average of 0.89%, suggesting the current entry point offers better income potential than recent historical norms.